Result Summary for EGF19060
| Protocol ID: | EGF19060 |
| Clinical Study ID: | EGF19060 |
| Official Title: | An Open Label, Phase 1b Rollover Study to Assess the Long-Term Safety Profile of Lapatinib (GW572016) in Cancer Patients. |
| Phase: | phase 1 |
| Study Indications or Diseases: |
|
| Generic Name: | lapatinib |
| Trade/Product Name: | Tyverb,Tykerb,Tycerb |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
